JP Morgan analyst cuts H.B. Fuller's price forecast to $50, citing declining sales in the Health, Hygiene, and Consumable segment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback